Obalon Therapeutics, Inc.
(NASDAQ GS: OBLN)
Rigrodsky Law, P.A. is investigating Obalon Therapeutics, Inc. (“Obalon”) regarding possible breaches of fiduciary duties and other violations of law related to Obalon’s agreement to merge with ReShape Lifesciences, Inc.